About Us
We are an innovative chemical enterprise specializing in the R&D, custom synthesis, and large-scale manufacturing of high-quality peptides and related chemical derivatives. Equipped with advanced peptide synthesis platforms, a rigorous quality control system (including comprehensive HPLC and MS testing), and an experienced scientific team, we provide a seamless, one-stop solution from milligram-scale lab research to kilogram-scale commercial production for pharmaceutical companies, biotech firms, and research institutions worldwide.
Deeply rooted in peptide technology, our portfolio encompasses custom long peptides, complex modified peptides, cyclic peptides, and pharmaceutical-grade CDMO services. Driven by the core values of "Quality First, Technological Innovation, and Reliable Delivery," we are committed to helping clients shorten R&D cycles and reduce manufacturing costs through high-purity, highly consistent products. Looking to the future, we continue to push the boundaries of peptide synthesis, empowering breakthroughs in life sciences and novel drug discovery.
News
In the rapidly evolving global healthcare, cosmetics, and biotechnology markets, cross-border demand for small-molecule peptide raw materials and customized finished products continues to grow exponentially.
In peptide-based product development, pharmaceutical research, and cosmetic ingredient sourcing, sampling is a critical step in vendor qualification. Obtaining and testing initial peptide samples allows technical and procurement teams to verify product quality, analytical accuracy, and manufacturing consistency before committing to commercial-scale orders.
When sourcing peptides for drug discovery, cosmetic formulations, or high-purity biological research, selecting the right partner model within the supply chain is critical to project timelines and overall risk management. While trading companies offer convenience for multi-product sourcing, B2B procurement teams, technical managers, and R&D leaders increasingly choose to establish direct relationships with primary peptide manufacturers.
leave a message